Molecular glues blog thumbnail

Targeted protein degradation and induced proximity: Molecular glues landscape in drug discovery

With more and more molecular glues, induced proximity, and targeted protein degradation approaches crowding the clinic, a landscape view of this emerging field has critical implications in therapeutic areas like cancer, autoimmune, and neurodegenerative diseases. Learn more in our latest white paper with unique CAS insights, and a view to future opportunities.

Cover page of Targeted Protein and Induced Proximity white paper

Download the CAS Insights Report

Related CAS Insights

Highlights from the CAS Insights webinar on the pharmaceutical patent landscape

White immune cells attacking a large pink cancer cell on a red tissue surface.

New translational research in immuno-oncology may reach patients who do not respond to current therapies

Pharmaceutical capsule containing a glowing orange DNA helix on a dark circuit board background.

CAS Insights Report: Unlocking the future of pharmaceutical innovation through patent intelligence.

Gain new perspectives for faster progress directly to your inbox.